RemeGen Balance Sheet Health
Financial Health criteria checks 3/6
RemeGen has a total shareholder equity of CN¥2.7B and total debt of CN¥2.3B, which brings its debt-to-equity ratio to 85.4%. Its total assets and total liabilities are CN¥5.8B and CN¥3.1B respectively.
Key information
85.4%
Debt to equity ratio
CN¥2.27b
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥876.36m |
| Equity | CN¥2.66b |
| Total liabilities | CN¥3.09b |
| Total assets | CN¥5.75b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 9995's short term assets (CN¥2.5B) exceed its short term liabilities (CN¥1.6B).
Long Term Liabilities: 9995's short term assets (CN¥2.5B) exceed its long term liabilities (CN¥1.5B).
Debt to Equity History and Analysis
Debt Level: 9995's net debt to equity ratio (52.5%) is considered high.
Reducing Debt: 9995 had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 9995 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 9995 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 31.1% each year